doi: Li, X., Hou, G., Zhu, Z., Yan, F., Wang, F., Wei, D., Zheng, Y., Yuan, J., Zheng, W., Zhang, G., Meng, P., Guo, Y., Li, X., Yao, L., Shen, L., & Yuan, J
Compared with its homolog MFN2, MFN1 exhibits higher GTPase activity and relies more extensively on GTP hydrolysis to facilitate membrane fusion ( Under 4-HNEinduced lipid peroxidation, mitochondrial dynamics shift toward excessive fission
Singlet oxygen is notorious for rapidly oxidizing lipid membranes, mutating cellular DNA, and degrading essential proteins, all of which accelerate cellular aging and drive chronic inflammation
In some embodiments, the therapeutic agents and pharmaceutical formulations described herein may be useful in treating early disseminated Lyme disease (Stage 2) which may occur from about 30 days to about several weeks after the initial Bsl infection and may be characterized by symptoms such as, but not limited to, chills, fever, headaches, fatigue, pain, weakness or numbness in the arms, legs, vision changes, heart problems, such as palpitations, chest pain, rash may appear on body, facial paralysis (Bells palsy)
Hexarelin resembles GHRP-6 in structure and function, minus the appetite increase
